26doc039
10.3205/26doc039
urn:nbn:de:0183-26doc0394
Meeting Abstract
Safety and efficacy of an extended macular vision Intraocular Lens (IOL) for Age-Related Macular Degeneration (AMD) in Real-World Settings
Hengerer
Hengerer
Fritz
F
Augenklinik Bürgerhospital, Augenheilkunde, Frankfurt
author
Stanzel
Stanzel
Boris
B
Augenklinik Sulzbach, Sulzbach
author
Beckers
Beckers
Sebastian
S
Augenklinik Mallorca, Santa Ponca, Spanien
author
Badala
Badala
Federico
F
Micro Chirurgia Oculare, Milan, Italien
author
German Medical Science GMS Publishing House
Düsseldorf
610
20260617
engl
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).
M0651
039
38. Internationaler Kongress der Deutschen Ophthalmochirurgie (DOC)
Retina II
Nürnberg
20260618
20260620
FP 4.4
TextPurpose: To assess the safety and efficacy of the EyeMax Mono (SharpView Ophthalmology) extended macular vision intraocular lens (IOL), in patients with age-related macular degeneration (AMD) undergoing cataract surgery.Methods: This retrospective multicentre study analyzed real-world data from 196 AMD eyes (146 patients) across 15 medical centres in Europe. All eyes recieved the single-piece, hydrophobic acrylic, EyeMax Mono IOL. AMD severity was classified by the centre. Outcomes included intraoperative and postoperative complications and changes in corrected distance and near visual acuity (CDVA and CNVA, respectively).Results: The postoperative spherical equivalent was +1.25±1.32 D. Postoperative LogMAR CDVA improved significantly from a baseline of 0.57±0.38 to 0.38±0.34 (n=191, p<0.001), while CNVA improved from 0.49±0.32 at baseline to 0.35±0.27 postoperatively (n=141, p<0.001). Sixty-three percent gained >1 line of CDVA and 27.5% gained ≥ 3 lines. For CNVA, 41.5% gained >1 line, and 21.8% gained = 3 lines. The greatest gains occurred in intermediate AMD eyes: CDVA +0.21 logMAR, CNVA +0.12 logMAR. Only 2.1% of eyes lost >1 line of CDVA or CNVA.Conclusions: The EyeMax Mono intraocular lens (IOL) safely enhances both distant (CDVA) and near (CNVA) visual acuity in patients with age-related macular degeneration, particularly in eyes with intermediate AMD. These findings are consistent with those in the published scientific literature.
0
0
0
0